Dalian BIO-CHEM (603360.SS) Earnings Analysis
Dalian BIO-CHEM (603360.SS) next reports earnings on 2026-08-26. Trailing P/E 48.83.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603360.SS next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
603360.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | 0.1 CNY | n/a | n/a | n/a |
| 2024-08-28 | 0.1367 CNY | n/a | n/a | n/a |
603360.SS valuation and analyst view
| Trailing P/E | 48.83 |
|---|---|
| Trailing EPS | 0.27149 CNY |
| Price / book | 5.79 |
| Dividend yield | 0.00% |
| Market cap | 8.47B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dalian BIO-CHEM (603360.SS)'s next earnings date?
Dalian BIO-CHEM is next scheduled to report on 2026-08-26.
Did 603360.SS beat earnings last quarter?
Consensus estimate data was not available for 603360.SS's 2025-03-31 report.
What is 603360.SS's current P/E ratio and EPS?
603360.SS trades at a trailing P/E of 48.83 on trailing EPS of 0.27149073452237593 CNY.
What do analysts rate 603360.SS?
603360.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.